← Back
$HCWB All transactions

HCW Biologics Inc.

▲ BUY
10 / 10

Conviction

$ Value

$60K

Shares

8,054

Price

$7

Filed

May 20

Why this score? (10/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • 10%+ owner (+1)
  • Cluster: 5 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Wong Hing C

Title

Chief Executive Officer

CIK

0001866258

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-05-16

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

501,911

Footnotes

These shares were issued pursuant to a conversion of Unsecured Convertible Promissory Notes which were issued to six holders through a Company financing of an aggregate principal of $270,000 in one-year Notes. The Notes contained a mandatory conversion provision, which resulted in the Notes converting into shares of common stock at a mandatory conversion price of $7.45 per share as set by the registered offering. The Notes converted after the closing of the Company's registered offering on May 15, 2025. The conversion transaction also included an allocated portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.

Filing Info

Accession No.

0000950170-25-075259

Form Type

4

Issuer CIK

0001828673

Wong Hing C's History

Date Ticker Type Value
2025-05-16 HCWB $60K
2025-05-08 HCWB $2.4M
2025-05-07 HCWB $0

Other Insiders at HCWB (90d)

No other insider activity at this issuer in the last 90 days.